MACOVEN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Jun 2025)
What this means for you
Registered since 11 Feb 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Feb 2030: the §8 & §9 renewal).
Record
- Serial number
- 88554281
- Registration number
- 5984347
- Mark type
- Word mark
- Filed
- 31 Jul 2019
- Published for opposition
- 26 Nov 2019
- Registered
- 11 Feb 2020
- Next maintenance filing
- §8 & §9 renewal, due by 11 Feb 2030 (grace period to 11 Aug 2030)
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, cough and cold symptoms, congestion, respiratory ailments, migraines, sleep issues, depression, and neurological conditions
Owner
- Currax Pharmaceuticals LLC, Brentwood, TN, US
- Currax Pharmaceuticals LLC, Morristown, NJ, US
- Currax Pharmaceuticals LLC, Morristown, NJ, US
Prosecution history
- 07 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Feb 2025 — TEAS SECTION 8 & 15 RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2019 — PUBLISHED FOR OPPOSITION
- 06 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Oct 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER